Generation of a NONO homozygous knockout human induced pluripotent stem cell line by CRISPR/Cas9 editing

被引:2
|
作者
Yi, Tong
Bai, Rui
Sun, Hairui
Lan, Feng
Zhang, Hongjia
He, Yihua
机构
[1] Capital Med Univ, Beijing Anzhen Hosp, Beijing Key Lab Maternal Fetal Med & Fetal Heart, Beijing, Peoples R China
[2] Minist Educ, Key Lab Remodeling Related Cardiovasc Dis, Beijing Lab Cardiovasc Precis Med, Beijing, Peoples R China
[3] Capital Med Univ, Anzhen Hosp, Collaborat Innovat Ctr Cardiovasc Disorders, Beijing 100029, Peoples R China
基金
国家重点研发计划;
关键词
D O I
10.1016/j.scr.2020.101893
中图分类号
Q813 [细胞工程];
学科分类号
摘要
The non-POU domain containing octamer-binding gene (NONO) encodes a member of a small family of RNA-binding and DNA-binding proteins, whose variants can cause intellectual disability and congenital heart defects. In this study, we generated a homozygous NONO knockout (NONO-KO) induced pluripotent stem cell (iPSC) line (CMUi002-A-1) using the CRISPR/Cas9-based genome editing system. The gene-edited line had a normal karyotype, expressed pluripotency markers, and was able to differentiate into all three germ layers in vivo. This cell line will provide a platform to study the pathogenic mechanisms of noncompaction cardiomyopathy and neurocyte dysfunction related to NONO mutations.
引用
收藏
页数:4
相关论文
共 50 条
  • [21] Generation of a FMR1 homozygous knockout human embryonic stem cell line (WAe009-A-16) by CRISPR/Cas9 editing
    Giri, Subhajit
    Purushottam, Meera
    Viswanath, Biju
    Muddashetty, Ravi S.
    STEM CELL RESEARCH, 2019, 39
  • [22] Generation of a DKK2 homozygous knockout human embryonic stem cell line using the CRISPR/Cas9 system
    Zhang, Wang
    Li, Yuming
    Wang, Li
    Xin, Tao
    Zhang, Canwei
    STEM CELL RESEARCH, 2021, 57
  • [23] Establishment of a CIB1 knockout human pluripotent stem cell line via CRISPR/Cas9 genome editing technology
    Gong, Tingyu
    Liu, Dandan
    Wang, Xiaochen
    Zhou, Danni
    Tang, Ling
    Wang, Hao
    Su, Jun
    Liang, Ping
    STEM CELL RESEARCH, 2024, 81
  • [24] Generation of a KSCBi005-A-5(TLR8KO-A10) homozygous knockout human induced pluripotent stem cell line using CRISPR/Cas9
    Han, Hyeong-jun
    Han, Hyo-Won
    Seo, Hyang-Hee
    Kim, Jung-Hyun
    STEM CELL RESEARCH, 2019, 40
  • [25] Generation of a homozygous TAZ knockout hESCs line by CRISPR/Cas9 system
    Zhou, Meng
    Huang, Pufeng
    Bai, Rui
    Liu, Xujie
    STEM CELL RESEARCH, 2022, 64
  • [26] Generation of a TLR2 homozygous knockout human embryonic stem cell line WAe001-A-64 using CRISPR/Cas9 editing
    Getachew, Anteneh
    Yang, Zhen
    Huang, Xinping
    Wu, Feima
    Liu, Yan Ying
    Yan, Chen
    Yang, Fan
    Li, Yinxiong
    STEM CELL RESEARCH, 2021, 54
  • [27] Generation of a homozygous RANGRF knockout hiPSC line by CRISPR/Cas9 system
    Jiang, Meiling
    Tang, Chengcheng
    Luo, Xian
    Zhou, Xiaoqing
    Chen, Min
    Chi, Yue
    Lai, Liangxue
    Zou, Qingjian
    STEM CELL RESEARCH, 2023, 71
  • [28] Generation of a Bag1 homozygous knockout mouse embryonic stem cell line using CRISPR/Cas9
    Tang, Cheng-cheng
    Shan, Li Pik
    Wang, Wu-ming
    Lu, Gang
    Tare, Rahul S.
    Lee, Kenneth Ka Ho
    STEM CELL RESEARCH, 2017, 21 : 29 - 31
  • [29] Generation of a COL1A2 homozygous knockout stem cell line via CRISPR/Cas9 system
    Ma, Shuhong
    Saleem, Amina
    Li, Xiaowei
    Lu, Wen-Jing
    Jiang, Hongfeng
    STEM CELL RESEARCH, 2022, 59
  • [30] Generation of a homozygous GRIN2A gene knockout human embryonic stem cell line using CRISPR/Cas9 system
    Luo, Xian
    Yang, Kaiming
    Jiang, Meiling
    Chen, Tao
    Chi, Yue
    Ma, Bingxiu
    Lai, Liangxue
    Zou, Qingjian
    STEM CELL RESEARCH, 2023, 69